Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
PR Newswire, 810 Seventh Avenue, New York, NY 10019 - Wednesday August 13, 1997 - 5:50 PM EDT
1) Rate-based capitation payments and enhanced capitation rates must be developed.
2) The Department of Public Welfare and its contracted HMOs must be compelled to meet the terms of the federal HCFA waiver with regard to provision of geographically accessible and linguistically competent care.
3) Condition-specific quality assurance procedures and performance measures must be implemented to ensure that appropriate levels of care are being provided to individuals with special needs.
4) The Department's failure to link performance and financial incentives in any way must also be corrected.
Mr. Yoshiaki Yamasaki, a staff member of the Philadelphia EMA HIV Commission, the Title I HIV Planning Council, reiterated these points in his testimony and stressed the need for culturally and linguistically competent services through Health Choices. "To date, the Health Choices system has been ineffective in complying with the regulations that they are required to follow with regard to cultural and linguistical competency. After a year of `working with the community' the system is failing miserably at serving anyone speaking a language other than English."
In closing, Hochendoner expressed that "...Right now Health Choices constitutes neither an improvement in care at the consumer level nor a realistic cost savings to the tax payer and that this situation cannot be expected to change without dramatically increased oversight and close attention to the existing and burgeoning problems that now exist."
If you are interested in a full copy of Mr. Hochendoner's testimony, contact Michele Porreca at the Philadelphia AIDS Consortium at 215-985-6200.
SOURCE: Philadelphia AIDS Consortium
Copyright (c) 1997/PR NewsWire. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, PR Newswire, 810 Seventh Avenue, New York, NY 10019.
970813
PR970811
Copyright © 1997 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .